Cargando…
TTK (threonine tyrosine kinase) regulates the malignant behaviors of cancer cells and is regulated by microRNA-582-5p in ovarian cancer
There is growing evidence that threonine tyrosine kinase (TTK) dysregulation is linked to the progression of multiple malignancies. Nonetheless, the role of TTK in ovarian cancer (OC) remains unclear. The GEO2R method was employed to screen out the mRNAs that were abnormally expressed between OC tis...
Autores principales: | Lu, Na, Ren, Lixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806697/ https://www.ncbi.nlm.nih.gov/pubmed/34516342 http://dx.doi.org/10.1080/21655979.2021.1968778 |
Ejemplares similares
-
MiR-582-5p Inhibits Bladder Cancer-Genesis by Suppressing TTK Expression
por: Tian, Yudong, et al.
Publicado: (2020) -
Activation of tyrosine kinases by mutation of the gatekeeper threonine
por: Azam, Mohammad, et al.
Publicado: (2008) -
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
por: Liu, Yixuan, et al.
Publicado: (2021) -
Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer
por: Xie, Yuan, et al.
Publicado: (2017) -
CircRNA protein tyrosine phosphatase receptor type a suppresses proliferation and induces apoptosis of lung adenocarcinoma cells via regulation of microRNA-582-3p
por: Jiang, Jixin, et al.
Publicado: (2022)